Cellid Co.,Ltd. leads development of anti-cancer immunotherapy.
Induction of a wide range of immune responses
The anti-tumor immune effectors responsible for direct and indirect killing of the tumor cells in the body include cytotoxic T cells, natural killer cells, helper T cells, and antibodies.
Most cancer immunotherapies currently in use today utilize only a part of these immune effectors.
On the other hand, CeliVax activates all of these anti-tumor effectors simultaneously to maximize the effect of antitumor immunity.